OpenLB
Open Library of Bioscience
Advanced Search
Tropical medicine and infectious disease
Aug 23, 2022;7 (9):

Primary Cutaneous Cryptococcosis Caused by in an Elderly Patient.

Walter Belda, Ana T S Casolato, Juliana B Luppi, Luiz Felipe D Passero, Paulo R Criado
Author Information
  1. Walter Belda: Dermatology Department, Medical School, University of São Paulo, Clinics Hospital, São Paulo 05403-000, Brazil. ORCID
  2. Ana T S Casolato: Dermatology Department, Medical School, University of São Paulo, Clinics Hospital, São Paulo 05403-000, Brazil. ORCID
  3. Juliana B Luppi: Dermatology Department, Medical School, University of São Paulo, Clinics Hospital, São Paulo 05403-000, Brazil.
  4. Luiz Felipe D Passero: Institute of Biosciences, São Paulo State University (UNESP), São Vicente 11330-900, Brazil. ORCID
  5. Paulo R Criado: ABC School of Medicine, Fundação Universitária do ABC (FUABC), Santo André 09060-870, Brazil. ORCID
PMID: 36136617 DOI: 10.3390/tropicalmed7090206

Abstract

According to the spread of sp., fungal infections can be classified as primary or secondary. In primary cutaneous cryptococcosis, the fungi are restricted to the skin of the patients, without systemic involvement. The incidence of primary cutaneous cryptococcosis is high in patients with immunosuppression, and this type of infection is rarely observed in patients who are immunocompetent. In the present case report, a patient who is immunocompetent and has systemic comorbidity reported that, after skin trauma, ulcerovegetative lesions appeared in the right upper arm; the etiologic agent was identified as , serotype B. The cutaneous lesions healed completely after 5 months of fluconazole treatment.

Keywords

cryptococcosis cutaneous involvement immunocompetent patient

References

  1. Clin Microbiol Rev. 2014 Oct;27(4):980-1024 [PMID: 25278580]
  2. Eur J Dermatol. 2021 Oct 1;31(5):657-658 [PMID: 34726158]
  3. Clin Infect Dis. 2000 Jan;30(1):47-54 [PMID: 10619732]
  4. N Engl J Med. 1978 Apr 13;298(15):825-6 [PMID: 345120]
  5. An Bras Dermatol. 2016 Sep-Oct;91(5 suppl 1):29-31 [PMID: 28300886]
  6. Chest. 2006 Feb;129(2):333-340 [PMID: 16478849]
  7. AIDS. 2007 Oct 18;21(16):2119-29 [PMID: 18090038]
  8. J Am Acad Dermatol. 2000 Aug;43(2 Pt 2):344-5 [PMID: 10901718]
  9. Acta Clin Belg. 1996;51(2):111-7 [PMID: 8693868]
  10. Med Mycol. 2003 Jun;41(3):177-88 [PMID: 12964709]
  11. Emerg Infect Dis. 2011 Feb;17(2):193-9 [PMID: 21291588]
  12. Microb Pathog. 2022 May;166:105521 [PMID: 35436563]
  13. Expert Opin Pharmacother. 2012 Apr;13(6):783-9 [PMID: 22424297]
  14. Postepy Dermatol Alergol. 2020 Apr;37(2):154-158 [PMID: 32489347]
  15. Med Mycol. 2019 Feb 1;57(2):133-150 [PMID: 30329097]
  16. Pathogens. 2021 Dec 22;11(1): [PMID: 35055956]
  17. Front Microbiol. 2015 Jan 14;5:740 [PMID: 25642211]
  18. Dermatol Online J. 2020 Dec 15;26(12): [PMID: 33423425]
  19. Med Mycol J. 2019;60(4):101-107 [PMID: 31787730]
  20. Mycoses. 2019 Nov;62(11):1029-1034 [PMID: 31376185]
  21. J Fungi (Basel). 2018 Mar 07;4(1): [PMID: 29518906]
  22. J Exp Med. 1992 Jun 1;175(6):1685-95 [PMID: 1588288]
  23. Cureus. 2021 May 22;13(5):e15185 [PMID: 34178506]
  24. Mem Inst Oswaldo Cruz. 2018;113(7):e170554 [PMID: 29641639]
  25. J Clin Microbiol. 2009 Nov;47(11):3669-72 [PMID: 19794048]
  26. Am J Med Sci. 2022 Jan;363(1):75-79 [PMID: 35033296]
  27. J Fungi (Basel). 2021 Apr 09;7(4): [PMID: 33918572]
  28. Emerg Infect Dis. 2018 Nov;24(11):2095-2097 [PMID: 30334716]
  29. Microorganisms. 2020 Apr 23;8(4): [PMID: 32340403]
  30. Clin Infect Dis. 2001 Sep 1;33(5):690-9 [PMID: 11477526]
  31. Clin Infect Dis. 2010 Feb 1;50(3):291-322 [PMID: 20047480]
  32. Rev Inst Med Trop Sao Paulo. 2002 Jul-Aug;44(4):225-8 [PMID: 12219115]
  33. Mediators Inflamm. 2016;2016:7068287 [PMID: 27073297]
  34. Clin Pract Cases Emerg Med. 2021 Aug;5(3):345-349 [PMID: 34437044]
  35. Mycoses. 2005 Jul;48(4):238-41 [PMID: 15982204]
  36. Ocul Immunol Inflamm. 2018;26(4):518-522 [PMID: 28448725]
  37. Prog Neuropsychopharmacol Biol Psychiatry. 2022 Aug 30;118:110576 [PMID: 35588939]
  38. Rev Soc Bras Med Trop. 2021 Sep 06;54:e01692021 [PMID: 34495255]
  39. Int J Mol Sci. 2021 Nov 17;22(22): [PMID: 34830272]
  40. PLoS One. 2016 Nov 18;11(11):e0166759 [PMID: 27861555]
  41. Mem Inst Oswaldo Cruz. 2008 Aug;103(5):455-62 [PMID: 18797758]
  42. Semin Respir Crit Care Med. 2020 Feb;41(1):69-79 [PMID: 32000285]
  43. Infect Dis Clin North Am. 2021 Jun;35(2):493-514 [PMID: 34016288]
  44. Microorganisms. 2021 Dec 23;10(1): [PMID: 35056462]
  45. Germs. 2020 Dec 28;10(4):388-391 [PMID: 33489955]
  46. AIDS. 2009 Feb 20;23(4):525-30 [PMID: 19182676]
Case Reports

Word Cloud

Created with Highcharts 10.0.0cutaneousprimarycryptococcosispatientsimmunocompetentskinsystemicinvolvementpatientlesionsAccordingspreadspfungalinfectionscanclassifiedsecondaryfungirestrictedwithoutincidencehighimmunosuppressiontypeinfectionrarelyobservedpresentcasereportcomorbidityreportedtraumaulcerovegetativeappearedrightupperarmetiologicagentidentifiedserotypeBhealedcompletely5monthsfluconazoletreatmentPrimaryCutaneousCryptococcosisCausedElderlyPatient

Similar Articles

Cited By